News
Canada's Sepset Biosciences Developing Point-of-Care Sepsis MDx With Eye Toward US Commercialization
The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback